| 臺大學術典藏 |
2021-06-28T06:52:26Z |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; KENG-HSUEH LAN; Chen C.-H.; Yu H.-J.; Lai M.-K.; Cheng A.-L.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-28T06:52:25Z |
Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; KENG-HSUEH LAN; Yu H.-J.; Lai M.-K.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-28T06:52:24Z |
Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
|
Hou W.-H.; Huang C.-Y.; Wang C.-C.; KENG-HSUEH LAN; Chen C.-H.; Yu H.-J.; Liu S.-P.; Lai M.-K.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-15T03:12:10Z |
Surgical management in enterovesical fistula in crohn disease at a single medical center
|
Su Y.-R.; Shih I.-L.; Tai H.-C.; SHU-CHEN WEI; Lin B.-R.; Yu H.-J.; Huang C.-Y. |
| 臺大學術典藏 |
2021-06-02T05:43:49Z |
Anti-angiogenic effects and mechanism of prazosin
|
Liao C.-H.; JIH-HWA GUH; Chueh S.-C.; Yu H.-J. |
| 臺大學術典藏 |
2021-06-02T05:43:43Z |
Erratum: Anti-angiogenic effects and mechanism of prazosin (The Prostate (2011) 71 (976-984))
|
Liao C.-H.; JIH-HWA GUH; Chueh S.-C.; Yu H.-J. |
| 臺大學術典藏 |
2021-05-21T07:17:46Z |
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma
|
Hsu F.-M.; Hou W.-H.; Huang C.-Y.; Wang C.-C.; CHIAO-LING TSAI; Tsai Y.-C.; Yu H.-J.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-18T02:03:18Z |
Sympathetic vesicovascular reflex induced by acute urinary retention evokes proinflammatory and proapoptotic injury in rat liver
|
Yu H.-J.;Lin B.-R.;Lee H.-S.;Chia-Tung Shun;Yang C.-C.;Lai T.-Y.;Chien C.-T.;Hsu S.-M.; Yu H.-J.; Lin B.-R.; Lee H.-S.; CHIA-TUNG SHUN; Yang C.-C.; Lai T.-Y.; Chien C.-T.; Hsu S.-M. |
| 臺大學術典藏 |
2021-03-18T02:03:14Z |
Primary primitive neuroectodermal tumor of the urinary tract
|
Huang K.-H.;Chia-Tung Shun;Huang S.-Y.;Yu H.-J.;Chueh S.-C.;Chen J.; Huang K.-H.; CHIA-TUNG SHUN; Huang S.-Y.; Yu H.-J.; Chueh S.-C.; Chen J. |
| 臺大學術典藏 |
2021-03-18T02:03:05Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.;Chia-Tung Shun;Huang K.-H.;Huang C.-Y.;Tsai Y.-C.;Yu H.-J.;Pu Y.-S.; Chen C.-H.; CHIA-TUNG SHUN; Huang K.-H.; Huang C.-Y.; Tsai Y.-C.; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-18T02:03:02Z |
Characteristics of Female Non-Muscle-Invasive Bladder Cancer in Taiwan: Association with Upper Tract Urothelial Carcinoma and End-Stage Renal Disease
|
Chen C.-H.; CHIA-TUNG SHUN; Huang K.-H.; Huang C.-Y.; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:52Z |
A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer
|
Chen C.-H.; Yang H.-J.; CHIA-TUNG SHUN; Huang C.-Y.; Huang K.-H.; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:02Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.;Shun C.-T.;Huang K.-H.;Huang C.-Y.;Yu-Chieh Tsai;Yu H.-J.;Pu Y.-S.; Chen C.-H.; Shun C.-T.; Huang K.-H.; Huang C.-Y.; YU-CHIEH TSAI; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:00Z |
Down-regulation of PKC�a in renal cell carcinoma and its clinicopathological implications.
|
Pu Y.S.; Huang C.Y.; Chen J.Y.; Kang W.Y.; Lin Y.C.; Shiu Y.S.; Chuang S.J.; Yu H.J.; Lai M.K.; YU-CHIEH TSAI; Wu W.J.; Hour T.C. |
| 臺大學術典藏 |
2021-03-04T02:35:58Z |
Osteoblast-derived WISP-1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126
|
Tai H.-C.; Chang A.-C.; Yu H.-J.; Huang C.-Y.; YU-CHIEH TSAI; Lai Y.-W.; Sun H.-L.; Tang C.-H.; Wang S.-W. |
| 臺大學術典藏 |
2021-03-04T02:35:57Z |
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma
|
Hsu F.-M.; Hou W.-H.; Huang C.-Y.; Wang C.-C.; Tsai C.-L.; YU-CHIEH TSAI; Yu H.-J.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:56Z |
CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK/Akt/HIF-1�\-induced twist expression
|
Chen P.-C.;Tai H.-C.;Lin T.-H.;Wang S.-W.;Lin C.-Y.;Chao C.-C.;Yu H.-J.;Yu-Chieh Tsai;Lai Y.-W.;Lin C.-W.;Tang C.-H.; Chen P.-C.; Tai H.-C.; Lin T.-H.; Wang S.-W.; Lin C.-Y.; Chao C.-C.; Yu H.-J.; YU-CHIEH TSAI; Lai Y.-W.; Lin C.-W.; Tang C.-H. |
| 臺大學術典藏 |
2021-03-03T03:01:24Z |
Importance of urodynamic study before radical hysterectomy for cervical cancer
|
Ho-Hsiung Lin;Yu H.-J.;Sheu B.-C.;Huang S.-C.; HO-HSIUNG LIN; Yu H.-J.; Sheu B.-C.; Huang S.-C. |
| 臺大學術典藏 |
2021-03-03T03:01:12Z |
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms
|
Ho C.-H.;Chang T.-C.;Ho-Hsiung Lin;Liu S.-P.;Huang K.-H.;Yu H.-J.; Ho C.-H.; Chang T.-C.; HO-HSIUNG LIN; Liu S.-P.; Huang K.-H.; Yu H.-J. |
| 臺大學術典藏 |
2021-03-03T03:01:11Z |
Comparison of overall sexual function, sexual intercourse/activity, sexual satisfaction, and sexual desire during the three trimesters of pregnancy and assessment of their determinants
|
Chang S.-R.;Chen K.-H.;Ho-Hsiung Lin;Yu H.-J.; Chang S.-R.; Chen K.-H.; HO-HSIUNG LIN; Yu H.-J. |
| 臺大學術典藏 |
2021-03-03T03:01:09Z |
Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome
|
Hsiao S.-M.;Chang T.-C.;Wu W.-Y.;Chen C.-H.;Yu H.-J.;Ho-Hsiung Lin; Hsiao S.-M.; Chang T.-C.; Wu W.-Y.; Chen C.-H.; Yu H.-J.; HO-HSIUNG LIN |
| 臺大學術典藏 |
2021-03-03T03:00:57Z |
Corrigendum to "Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials", [Urol Sci, (2015), 41-48], doi:10.1016/j.urols.2014.12.010
|
Kuo H.-C.; HO-HSIUNG LIN; Yu H.-J.; Cheng C.-L.; Hung M.-J.; Lin A.T.L.; Chang C.-H.; Chuang Y.-C.; Cha T.-L.; Chen G.-D.; Chen C.-S.; Wu M.-P.; Wu T.-L.; Yu K.-J.; Huang S.-T.; The Taiwan Mirabegron Study Team |
| 臺大學術典藏 |
2021-03-03T03:00:57Z |
Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials
|
Kuo H.-C.; HO-HSIUNG LIN; Yu H.-J.; Cheng C.-L.; Hung M.-J.; Lin A.T.L. |
| 臺大學術典藏 |
2021-02-08T07:23:56Z |
Secular trend and age-period-cohort analysis of prostate cancer mortality in Taiwan
|
Chang C.-K.;Yu H.-J.;Kin-Wei Chan;Lai M.-K.; Chang C.-K.; Yu H.-J.; KIN-WEI CHAN; Lai M.-K. |
| 臺大學術典藏 |
2021-02-08T07:23:55Z |
Factors related to delayed treatment and posttreatment symptom severity in Taiwanese patients with benign prostatic hyperplasia
|
Chang C.-K.;Yu H.-J.;Kin-Wei Chan;Chie W.-C.;Chen J.;Chen Y.-T.;Lai M.-K.; Chang C.-K.; Yu H.-J.; KIN-WEI CHAN; Chie W.-C.; Chen J.; Chen Y.-T.; Lai M.-K. |
